Immune system guards stand watch inside the lungs. These defenders are called resident memory B cells. They help protect people from influenza reinfection after illness ends. New research now shows how these cells survive. The findings could help scientists design stronger vaccines that better defend the lungs.
B cells are part of the adaptive immune system. They help the body recognize past threats and respond faster later. Some B cells circulate through blood and lymph tissue. Others stay stationed inside organs like the lungs. These resident memory B cells act like sentinels at a gate. If influenza returns, they can respond quickly where the virus attacks first.
Researchers wanted to understand how these lung-based cells form and remain active over time. Earlier studies showed resident memory B cells can stay in lung tissue for months after infection. However, scientists still did not fully understand what controls their long-term survival.
To investigate this mystery, researchers used a mouse model infected with influenza. They tracked how memory B cells developed after infection. The team found that these cells formed mainly during the first two weeks after illness began. Once established, they remained in the lungs for at least six months.
What Were the Findings?
The researchers found that resident memory B cells differ from circulating memory B cells. They show unique surface traits and different gene activity patterns. This suggests they are specially adapted for life inside lung tissue.
A key discovery involved signals from the B cell receptor. This receptor helps B cells sense threats and receive survival instructions. The strength of these signals influenced whether memory B cells remained in the lungs long term.
When receptor signaling was altered, the number and persistence of resident memory B cells changed. Receptor activity played a central role in maintaining these cells over time. Without the right signals, lung memory B cells did not remain as effectively. That could leave the respiratory tract more vulnerable to future infection.
To uncover these mechanisms, the team used a CRISPR-Cas9 genetic screen. This tool allows scientists to test how specific genes affect cell behavior. Researchers applied genetic screening to infected mice. Insodoing, they identified transcription factors linked to BRM cell formation and persistence.
What’s Next?
The findings may have important vaccine implications. Many current flu vaccines aim to generate circulating antibodies in the bloodstream. Those antibodies can help, but they may not always create strong local protection in the lungs.
Future vaccines could take a different path. Instead of only boosting antibodies, they may try to build lasting immune defenses inside respiratory tissue. Encouraging the growth and survival of resident memory B cells could provide faster protection.
That strategy may not only help against influenza. It could also improve defenses against other respiratory threats. Scientists are still learning how tissue-based immunity works. Still, this study offers a clearer roadmap for stronger lung protection in the future.
Conclusion
New research found that long-lasting immune B cells in the lungs help stop flu reinfection. Scientists discovered that signals inside these cells control how long they stay active. Future vaccines may protect lungs better by building these local immune guards.
Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.
Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

